Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -1,906 | -987 | -1,296 | -2,603 |
| Depreciation Amortization | N/A | 424 | 319 | 177 | 123 |
| Other Working Capital | N/A | -398 | 23 | 42 | 639 |
| Other Operating Activity | -362 | 700 | -6 | 116 | 409 |
| Operating Cash Flow | $-362 | $-1,180 | $-651 | $-961 | $-1,433 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -399 | -165 | -144 | -71 | -109 |
| Other Investing Activity | -638 | 138 | 261 | -133 | 381 |
| Investing Cash Flow | $-1,037 | $-26 | $117 | $-204 | $272 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | 13 | N/A | N/A |
| Other Financing Activity | 585 | 2,052 | 881 | 92 | -79 |
| Financing Cash Flow | $585 | $2,052 | $893 | $92 | $-79 |
| Beginning Cash Position | N/A | 1,102 | 694 | 1,767 | 3,007 |
| End Cash Position | N/A | 1,948 | 1,053 | 694 | 1,767 |
| Net Cash Flow | $-814 | $846 | $360 | $-1,073 | $-1,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -362 | -1,180 | -651 | -961 | -1,433 |
| Free Cash Flow | -362 | -1,180 | -651 | -961 | -1,433 |